Examining Patient Preferences About the IBM Watson Oncology Clinical Decision Support System

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

September 15, 2015

Primary Completion Date

June 22, 2020

Study Completion Date

June 22, 2020

Conditions
Breast CancerLung CancerColorectal Cancer
Interventions
BEHAVIORAL

Focus groups

After the presentation of the of IBM Watson Oncology at the opening of the focus group, participants will be asked to fill out a de-identified brief 15-item questionnaire to assess participants' first impressions of IBM Watson Oncology. The questionnaire will be self administered, and will take approximately 5 minutes to complete. Completed questionnaires will be collected by a member of the study staff, and the focus group will proceed with introductions. The focus group will be audio recorded from the completion of the introductions and notes will be taken. The focus group guide will address the study aims. At the end of the focus group, participants will complete a 7-item questionnaire to capture simple demographic information including education, income, and health literacy. This questionnaire will take 3-5 minutes to complete.

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT02565017 - Examining Patient Preferences About the IBM Watson Oncology Clinical Decision Support System | Biotech Hunter | Biotech Hunter